tirzepatide/mounjaro FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Mounjaro (tirzepatide): Dual-Action Diabetes and

In December 2025, the Centers for Medicare & Medicaid Services introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model

Some people may lose more weight with Ozempic than others, which can lead to more noticeable changes in their facial appearance

Public Enemy Number One: Americas public enemy number one in the United States is drug abuse

The SHapley Additive exPlanation method was used to elucidate how each covariate influenced the risk of hypoglycemia

Important safety considerations include the risk of acute pancreatitis (seek urgent medical attention for severe, persistent abdominal pain), gallbladder disease, and potential worsening of diabetic retinopathy, particularly in patients with pre-existing retinopathy who experience rapid improvement in blood glucose control